retatrutide death Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide and Heart Issues: Cardiovascular
Description
This is encouraging, but the data is observational rather than from controlled trials
Until the data of the SURPASS-CVOT trial are available, tirzepatide will most likely have a place in the algorithm of T2D therapy for patients with obesity and T2D that have the therapeutic aim to normalize glycemia and decrease body weight
Taxes/fees may apply
However, the potential risk of obstetric complications specifically for semaglutide, the next generation of GLP-1 RA, has not been previously evaluated
Burholt, W
